Introduction
A variety of probiotic lactic acid bacteria (LAB) evoke immunomodulatory effects in the host, including protection against viral and pathogenic bacterial infections and suppression of allergic responses (1) . Among them, Lactobacillus strains are known to be strong inducers of pro-inflammatory cytokines such as IL-12 and TNF-α in the gut (2, 3) . In our previous screening of Lactobacillus strains to identify their anti-allergic properties, we have reported that oral administration of Lactobacillus acidophilus L-92 reduces the production of antigen-specific serum IgE in mice (4) . Moreover, clinical studies demonstrated that orally administered L-92 could alleviate symptoms of pollen allergy (5) , perennial allergy (6) and atopic dermatitis (7, 8) . It has also been reported that L-92 exerts various immunomodulatory functions in mice, such as an increase in the T h 1 and T h 2 ratio, induction of apoptosis in antigen-stimulated T cells, production of IgA in Peyer's patches (PPs) and an increase in T reg cells (9) (10) (11) .
The immunomodulatory functions of orally administered L-92 are likely mediated by their uptake into the gut-associated lymphoid tissue (GALT) to modulate mucosal as well as systemic immune responses. GALT, represented by PPs, is the organized immunoinductive site in the intestine. Initiation of GALT immune responses requires the direct sampling of luminal antigens including bacteria across the mucosal epithelium. Microfold cells (M cells) in the follicle-associated epithelium (FAE) covering the GALT lymphoid follicles have a high capacity for the transport of luminal antigens such as bacteria and viruses to underlying immune cells, especially antigen-presenting dendritic cells (DCs) (12) . The uptake of bacteria requires specific receptors expressed on M cells. For example, glycoprotein 2 (GP2), a glycosylphosphatidylinositol (GPI)-anchored protein, is specifically expressed on M cells among intestinal epithelium, where it acts as a transcytotic receptor for type 1-piliated bacteria such as Escherichia coli and Salmonella enterica serovar Typhimurium (13) . Cellular prion protein (PrP C ), another GPIanchored protein, is also expressed on M cells and specifically binds to Brucella abortus via HSP60 on the bacterial surface for subsequent delivery of the bacteria to PPs (14) . Thus, we hypothesized that L-92 would also be transported to PPs via a bacterial receptor on M cells to exert its immunomodulatory functions.
We here report that L-92 is delivered to PP DCs by M cells. We further demonstrate that the interaction of surface layer protein A (SlpA) on L-92 with a GPI-anchored protein uromodulin (also known as Tamm-Horsfall protein) on M cells is responsible for M cell-mediated uptake of L-92.
Methods

Bacteria
L. acidophilus L-92 and CP23 strains from our stock culture collection were cultured anaerobically in Man Rogosa Sharpe (MRS) broth (Difco Laboratories) at 37°C for 20 h.
Animals
C57BL/6J and BALB/c mice were purchased from CLEA Japan. Umod −/− mice (15) were crossed with BALB/c or C57BL/6 to obtain Umod +/− mice. These mice were further crossed and resultant Umod −/− and Umod +/+ mice in BALB/c were used for the whole-mount immunostaining, while those in C57BL/6 were used for the ligated loop assay. Mice were maintained in animal facilities of RIKEN and Yokohama City University under specific pathogen-free conditions. Animal experiments were approved by the Institutional Animal Care and Use Committee of RIKEN Yokohama Branch and that of Yokohama City University.
Ligated intestinal loop assay
L-92 cells were treated with 5 mol l −1 LiCl for 30 min at room temperature to remove the Slp (LiCl-L-92), then the cells were collected after centrifugation at 6000 g for 10 min. The ligated intestinal loop assay was performed as described previously with minor modifications (16) . Briefly, a mouse intestinal loopcontaining PPs was prepared after anaesthetization with isoflurane (Mylan Inc.). Under anesthesia, a total of 1 × 10 8 of Lactobacillus L-92 or LiCl-L-92 cells labeled with Cy3 MonoReactive Dye Pack (GE Healthcare) or Alexa Fluor® 350 carboxylic acid, succinimidyl ester (Invitrogen) were injected into the ligated loop. After 60 min, mice were sacrificed, and PPs were excised from the intestine. PP specimens were fixed with Cytofix/Cytoperm (BD Biosciences) and blocked by incubation with PBS containing 0.2% bovine serum albumin (BSA) (Wako). Then specimens were permeabilized with 0.1% Saponin (Sigma) and incubated with an anti-mouse GP2 monoclonal antibody (clone 2F11-C3) (13) and biotinylated hamster anti-mouse CD11c (clone HL3) (BD Pharmingen™) for overnight at 4°C. The binding of primary antibodies was followed by the secondary antibodies conjugated with Alexa Fluor® 488 (Invitrogen) and Cy5-conjugated Streptavidin (Invitrogen). Samples were analyzed with a DM-IRE2 confocal laser scanning microscope (Leica Microsystems) and a DeltaVision Restoration deconvolution microscope (Applied Precision).
Whole mount immunostaining
PPs dissected from Umod +/+ and Umod −/− mice were washed with cold HBSS, and then fixed sequentially with methanol and acetone for 30 min each at −20°C. After the fixation, PPs were washed with cold PBS and incubated with sheep anti-uromodulin polyclonal antibody (R&D Systems, Inc. Minneapolis, MN, USA) and rat anti-mGP2 monoclonal antibody (clone: 2F11-C3) overnight at 4°C. The binding of anti-GP2 and uromodulin antibodies was visualized by incubation with Alexa Fluor® 488 donkey anti-rat IgG and Alexa Fluor® 555 donkey anti-sheep IgG antibodies for 2 h at 4°C. Immunostained PPs were analyzed by a confocal laser microscope (SP5, Leica Microsystems).
Preparation of recombinant mouse uromodulin protein
To obtain a fusion protein of mouse uromodulin with the Fc fragment of human IgG 1 (hIgG 1 ) (mUmod-Fc), RIKEN FANTOM clone D630003D16 was used as a template for PCR amplification. Primers used were as follow: 5′-CGCAGATCTACCATGGGGATCCCTTTGACC-3′ (forward) and 5′-CGCGTCGACCTTGGACACTGAGGCCTGG-3′ (reverse). The resulting cDNA fragment was inserted into the BglII/SalI cloning sites of a pcDNA3 expression vector (Invitrogen) containing a fragment encoding the Fc segment of hIgG 1 to obtain mUmod-Fc. Recombinant protein was prepared as described previously (13) . ) were immobilized in 96-well flat bottom plates (Nunc) by adding 50 µl of the protein solution into each well and incubating overnight at 4°C. After washing three times with PBS, the wells were incubated with 1% BSA-PBS for 2 h for blocking, and then incubated for 2 h with 1 × 10 6 bacterial cells at room temperature. To study the effect of anti-SlpA antibody on L-92 binding to Umod, L-92 cells were incubated with anti-SlpA antibody for 1 h before the binding assay. After washing the wells five times with PBS, genomic DNA was extracted from bound bacteria with NucleoSpin® Tissue (Takara). The copy number of 16S ribosomal RNA (rRNA) genes was determined by realtime qPCR with SYBR premix Ex Taq (Takara) as described previously (13) .
In vitro bacterial binding assay
In vivo assessment of M-cell uptake of fluorescent nanoparticles
L-92 cells were suspended in 5 mol l −1 LiCl for 30 min at room temperature. After centrifugation, SlpA was prepared from the dialyzed (20 mM MES buffer) supernatant as a major protein (Dojindo). SlpA protein or BSA was covalently bound to 1.0-µm-diameter green or orange FluoSpheres® carboxylate-modified microspheres (Invitrogen) according to manufacturer's recommendation. Green-or orange-labeled particles (2 × 10 9 ), with or without covalently linked SlpA or BSA, were injected into intestinal loops containing PPs (16) . After incubation for 60 min, the mice were euthanized and PPs were excised from the intestine and embedded in Optimal Cutting Temperature (OCT) compound (Sakura Finetek). Quantification of fluorescent beads taken up into PPs was performed by counting incorporated fluorescent beads in the frozen section on images acquired with a confocal laser microscope (SP5, Leica Microsystems).
Results
M cells take up and transfer L. acidophilus L-92 to DCs
To examine whether L-92 is taken up by M cells, we employed the ligated intestinal loop assay (16) . L-92 was labeled with Cy3 and injected into ileal loop-containing PPs, which were then dissected and analyzed for the presence of bacteria by confocal laser microscopy. Whole-mount staining of the PPs demonstrated the co-localization of the M-cell-specific marker GP2 and Cy3-labeled L-92 (Fig. 1A, arrowheads) indicating that L-92 was taken up into M cells. We also observed that L-92 was co-localized with CD11c-positive cells closely associated with GP2-positive M cells ( Fig. 1B and C ; Supplementary Movie, available at International Immunology Online). These data suggest that L-92 can be transported across the epithelial barrier to PP DCs via M cells to exert its immunomodulatory effects.
Uromodulin on M cells serves as an endocytic receptor for L-92
Several GPI-anchored proteins expressed on M cells, such as GP2 (13) and PrP C (14) , have been shown to serve as bacterial transport receptors. Recently, another GPI-anchored protein uromodulin was reported to be expressed on the M cell surface (17) , as confirmed in our immunostaining of PP FAE which revealed the partial co-localization of uromodulin and GP2 (Fig. 2) .
We reasoned that uromodulin could serve as an uptake receptor for L-92, since our preliminary study had suggested that several Lactobacillus species were among the bacteria in the mouse cecum that bound to a recombinant mouse uromodulin-human IgG 1 -Fc fusion protein (mUmod-Fc). To test this possibility, we performed an in vitro binding assay with mUmod-Fc and L-92. As shown in Fig. 3(A (Fig. 3B ). Taken together, these observations suggest that uromodulin expressed on M cells plays a crucial role in the binding and uptake of L-92 into M cells.
SlpA on L-92 mediates binding of L-92 with uromodulin
We further explored the molecular basis for the interaction of L-92 with uromodulin. SlpA is a major Slp on L. acidophilus including L-92 (18) . We therefore examined whether SlpA was involved in the interaction of L-92 with uromodulin. SlpA attaches non-covalently to the outer surface of the bacterial cell wall and can be detached by LiCl treatment (18) . We confirmed that LiCl-treated L-92 lost virtually all surface staining with an SlpA-specific antibody (Fig. 4A) . Compared to untreated L-92, LiCl-treated L-92 also had a significant decrease in the binding of mUmod-Fc (Fig. 4B) . Furthermore, binding of L-92 to mUmod-Fc was impaired when L-92 was pre-treated with the SlpA-specific antibody (Fig. 4C ). These observations suggest that SlpA on the L-92 surface is involved in binding of the bacteria to uromodulin on M cells.
SlpA promotes the uptake by M cells
Consistent with the results of the in vitro binding assays, the internalization of L-92 by PP M cells was significantly impaired when L-92 was pre-treated with LiCl to remove SlpA (Fig. 5A) . Moreover, covalent attachment of SlpA to the surface of fluorescence-labeled nanobeads significantly increased their uptake into PP M cells (Fig. 5B) . These results underscore the biological significance of the SlpA-uromodulin interaction in the uptake of L-92 by M cells.
Discussion
Uromodulin was originally identified as a protein abundant in urine and associated with protection against urinary tract infections and renal lithiasis (15, 19) . Uromodulin has also recently been shown to be expressed on intestinal M cells (17) . In the present study, we demonstrated that uromodulin expressed on M cells is required for the efficient uptake of L. acidophilus L-92 into M cells. Uropathogenic bacteria such as E. coli, Pseudomonas aeruginosa and Klebsiella pneumoniae also bind to uromodulin (15, 20) ; however, the molecular basis of the interaction between these bacteria and uromodulin has not been clarified. We here show that SlpA on L-92 mediates the binding of the bacterium to uromodulin.
Slps expressed on Lactobacillus species bind to mucin (21) and extracellular matrix proteins in vitro (22, 23) . We have also reported that SlpA is important for bacterial attachment to the Caco-2 intestinal epithelial cell line (18) . However, In conclusion, we were able to demonstrate a crucial role of uromodulin specifically expressed on M cells among the intestinal epithelium for the uptake of SlpA-positive L. acidophilus L-92 into M cells, leading to the subsequent delivery of the bacteria to DCs closely associated with M cells for immunomodulation. SlpA-positive Lactobacillus bacteria thus can be used as probiotics to promote host gut immunity, and moreover, SlpA and uromodulin could be used as vehicle and target, respectively, for efficient mucosal vaccine delivery.
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